1. Home
  2. DAKT vs DVAX Comparison

DAKT vs DVAX Comparison

Compare DAKT & DVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DAKT
  • DVAX
  • Stock Information
  • Founded
  • DAKT 1968
  • DVAX 1996
  • Country
  • DAKT United States
  • DVAX United States
  • Employees
  • DAKT N/A
  • DVAX N/A
  • Industry
  • DAKT Office Equipment/Supplies/Services
  • DVAX Biotechnology: Pharmaceutical Preparations
  • Sector
  • DAKT Industrials
  • DVAX Health Care
  • Exchange
  • DAKT Nasdaq
  • DVAX Nasdaq
  • Market Cap
  • DAKT 991.0M
  • DVAX 1.2B
  • IPO Year
  • DAKT 1994
  • DVAX 2004
  • Fundamental
  • Price
  • DAKT $19.52
  • DVAX $10.30
  • Analyst Decision
  • DAKT Strong Buy
  • DVAX Buy
  • Analyst Count
  • DAKT 1
  • DVAX 4
  • Target Price
  • DAKT $26.00
  • DVAX $26.50
  • AVG Volume (30 Days)
  • DAKT 485.3K
  • DVAX 1.2M
  • Earning Date
  • DAKT 12-03-2025
  • DVAX 11-05-2025
  • Dividend Yield
  • DAKT N/A
  • DVAX N/A
  • EPS Growth
  • DAKT 9.66
  • DVAX N/A
  • EPS
  • DAKT 0.23
  • DVAX N/A
  • Revenue
  • DAKT $749,361,000.00
  • DVAX $316,268,000.00
  • Revenue This Year
  • DAKT $12.94
  • DVAX $23.23
  • Revenue Next Year
  • DAKT $7.16
  • DVAX $16.57
  • P/E Ratio
  • DAKT $83.36
  • DVAX N/A
  • Revenue Growth
  • DAKT N/A
  • DVAX 26.66
  • 52 Week Low
  • DAKT $10.24
  • DVAX $9.20
  • 52 Week High
  • DAKT $24.38
  • DVAX $14.63
  • Technical
  • Relative Strength Index (RSI)
  • DAKT 45.45
  • DVAX 54.73
  • Support Level
  • DAKT $19.58
  • DVAX $10.03
  • Resistance Level
  • DAKT $21.00
  • DVAX $10.59
  • Average True Range (ATR)
  • DAKT 0.58
  • DVAX 0.23
  • MACD
  • DAKT -0.04
  • DVAX 0.05
  • Stochastic Oscillator
  • DAKT 24.01
  • DVAX 67.05

About DAKT Daktronics Inc.

Daktronics Inc designs and manufactures electronic scoreboards, programmable display systems, and large-screen video displays for sporting, commercial, and transportation applications. It is engaged in a full range of activities: marketing and sales, engineering and product design and development, manufacturing, technical contracting, professional services, and customer service and support. The company offers a complete line of products, from small scoreboards and electronic displays to large multimillion-dollar video display systems as well as related control, timing, and sound systems. The company has five reportable segments: Commercial, Live Events, High School Park and Recreation, Transportation, and International. The company makes the majority of its revenue from Live events.

About DVAX Dynavax Technologies Corporation

Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.

Share on Social Networks: